ロード中...
In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication
A novel coronavirus, named SARS-CoV-2, emerged in 2019 in China and rapidly spread worldwide. As no approved therapeutics exists to treat COVID-19, the disease associated to SARS-Cov-2, there is an urgent need to propose molecules that could quickly enter into clinics. Repurposing of approved drugs...
保存先:
| 出版年: | Sci Rep |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7403393/ https://ncbi.nlm.nih.gov/pubmed/32753646 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-70143-6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|